Seeding fresh bone marrow aspirate directly on scaffolds to construct tissue-engineered ligament
10.3969/j.issn.2095-4344.2014.12.011
- VernacularTitle:新鲜骨髓吸出物直接种植于支架构建组织工程韧带
- Author:
Hong WANG
;
Ming TANG
;
Chunqing MENG
;
Hanqi WANG
;
Shuhua YANG
;
Jingyuan DU
;
Deyu DUAN
;
Zengwu SHAO
- Publication Type:Journal Article
- Keywords:
biocompatible materials;
stents;
ligaments;
bone marrow
- From:
Chinese Journal of Tissue Engineering Research
2014;(12):1870-1876
- CountryChina
- Language:Chinese
-
Abstract:
BACKGROUND:There are several reports about the application of fresh bone marrow aspirate being injected directly to repair partial ligament injury, but the application about fresh bone marrow aspirate directly being planted on scaffolds to build tissue-engineered ligament is rarely mentioned.
OBJECTIVE:To evaluate the feasibility of applying fresh bone marrow aspirate planted directly on scaffolds to construct tissue-engineered ligament
METHODS:We constructed fibroin fiber/smal intestinal submucosa composite scaffold, then planting fresh bone marrow directly to built bone marrow seeding group and planting seed cel s (bone marrow mesenchymal stem cel s) on the scaffold to built cel seeding group. The control group had no treatment. After that, we detected the density of cel adhesion, cel proliferation ability and extracel ular matrix secretion. Then, the composite in the bone marrow seeding group was implanted into the broken anterior cruciate ligament in rabbits, and material biocompatibility in vivo was evaluated after 12 weeks.
RESULTS AND CONCLUSION:After 4 hours of incubation, bone marrow seeding group was significantly higher than the cel seeding group in cel adhesion density and proliferation rate (P<0.05). Bone marrow seeding group and cel seeding group showed higher type I, III col agen secretion compared with the control group (P<0.05), but the col agen secretion of bone marrow seeding group and cel seeding group showed no significant difference. Composite cel scaffold implantation in vivo did not cause fatal immune rejection and severe inflammatory reaction, and no significant ligament regeneration and vascularization occurred. These findings indicate that fresh bone marrow aspirate can be seeded directly on scaffolds to construct tissue-engineered ligament, and the short-term biocompatibility in vivo is good.
